ArticlePharmaceutics2022

A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin.

Xuezhi Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.